Cargando…
Identification of a Subset of Microsatellite-Stable Endometrial Carcinoma with High PD-L1 and CD8+ Lymphocytes
Immune checkpoint blockade has emerged as an effective therapeutic strategy for patients with advanced cancer. Identification of biomarkers associated with treatment efficacy will help to select patients more likely to respond to this approach. High levels of microsatellite instability, tumor expres...
Autores principales: | Crumley, Suzanne, Kurnit, Katherine, Hudgens, Courtney, Fellman, Bryan, Tetzlaff, Michael T., Broaddus, Russell |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6395512/ https://www.ncbi.nlm.nih.gov/pubmed/30291344 http://dx.doi.org/10.1038/s41379-018-0148-x |
Ejemplares similares
-
CTNNB1 (beta-catenin) mutation identifies low grade, early stage endometrial cancer patients at increased risk of recurrence
por: Kurnit, Katherine C., et al.
Publicado: (2017) -
Lymphocyte activation gene (LAG)-3 is a potential immunotherapeutic target for microsatellite stable, programmed death-ligand 1 (PD-L1)-positive endometrioid endometrial cancer
por: Hong, Jin Hwa, et al.
Publicado: (2022) -
Characterisation of PD-L1-positive subsets of microsatellite-unstable colorectal cancers
por: Kim, Jung Ho, et al.
Publicado: (2016) -
Microsatellite-stable diploid carcinoma: a biologically distinct and aggressive subset of sporadic colorectal cancer
por: Hawkins, N J, et al.
Publicado: (2001) -
Homologous Recombination Repair Truncations Predict Hypermutation in Microsatellite Stable Colorectal and Endometrial Tumors
por: Lee, Minyi, et al.
Publicado: (2020)